[ad_1]
Pfizer seeks approval of Corona 19 vaccine in Europe … “Vaccination available this month”
Pfizer, a US pharmaceutical company, and Bio-Ntech, Germany, have applied for marketing approval of the COVID-19 vaccine developed jointly by the European Medicines Agency.
If the approval process goes as planned, the vaccine will be available later this month.
If approved, the drug can be marketed for one year in 27 EU Member States before all the necessary information on the drug’s effectiveness and side effects is available.
Pfizer-Bio Entech previously announced the final results of a Phase 3 clinical study that the immune effect of the COVID-19 vaccine was 95% and requested emergency use of the vaccine to the U.S. Food and Drug Administration. on the 20th of last month.
Yonhap News TV article inquiries and reports: katok / line jebo23
(End)
Source link
